Edwards Lifesciences Corp. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
209.39 M |
Public Float |
187.81 M |
Edwards Lifesciences Corp. | |
Stock Exchange | New York Stock Exchange |
EPS |
$3.59 |
Market Cap |
$39.26 B |
Shares Outstanding |
208.5 M |
Public Float |
206.21 M |
Address |
One Edwards Way Irvine California 92614 United States |
Employees | - |
Website | http://www.edwards.com |
Updated | 07/08/2019 |
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World. Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. |